Bart Henderson
Founder at Torque Therapeutics, Inc.
Profile
Bart Henderson is the founder of Rhythm Pharmaceuticals, Inc. (founded in 2008) and Allergan GI Corp.
(founded in 2008).
He is also the founder of Radius Health, Inc., Torque Therapeutics, Inc. Mr. Henderson's current job is Chief Executive Officer at Wavebreak Therapeutics Ltd.
Mr. Henderson's former jobs include Marketing Manager-Neupogen at Amgen, Inc., Product Manager at Merck & Co., Inc., Head-Marketing at Vertex Pharmaceuticals, Inc. (from 1996 to 2001), Vice President-Business Development at Ironwood Pharmaceuticals, Inc., and Entrepreneur-in-Residence at MPM BioImpact, Inc. Mr. Henderson received his undergraduate degree from Amherst College and his MBA from Tuck School of Business at Dartmouth.
Bart Henderson active positions
| Companies | Position | Start |
|---|---|---|
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Founder | - |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Chief Executive Officer | 2022-03-03 |
Former positions of Bart Henderson
| Companies | Position | End |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Chief Executive Officer | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Sales & Marketing | 2000-12-31 |
| RADIUS HEALTH, INC. | Founder | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Corporate Officer/Principal | - |
Training of Bart Henderson
| Amherst College | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Health Technology |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Bart Henderson
